Welcoming Artificial to the M12 portfolio
We’re thrilled to welcome Artificial—a software company building a first-of-its-kind lab automation platform—to the M12 portfolio as lead of their Series A round. Biology research labs have yet to have their Industrial and Digital Revolutions. When I started my academic research career at the National Institutes of Health 21 years ago and my biopharmaceutical career at Novartis 15 […]
Irad Dor joins M12 as the fund’s newest partner
It is my pleasure to welcome Irad Dor as our newest partner at M12, Microsoft’s venture fund. Based in Tel Aviv, Irad will focus on early-stage investments in cloud infrastructure, cybersecurity and enterprise software in Israel and the broader EMEA region. “I’m excited to join M12 at the fund’s five-year milestone. The team has built a reputation […]
Congratulating Aqua on their unicorn status
I’m thrilled to congratulate Aqua — the complete cloud native security platform — on their latest funding round and unicorn status. M12’s initial investment in Aqua as lead of their series A round was announced in September 2016, just months after our fund was founded. While their product offering has evolved and expanded greatly since […]
Congratulating Innovaccer on their unicorn status
I’m thrilled to congratulate Innovaccer — a leading healthcare technology company on a mission to help healthcare care as one — on their latest funding round and unicorn status. M12’s initial investment in Innovaccer was announced in January 2019, marking our firm’s inaugural deal in India. Since that Series B investment, we’ve witnessed the impact that Innovaccer is having […]